VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+11.92%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$191M
AUM Growth
-$59.3M
(-24%)
Cap. Flow
-$77.9M
Cap. Flow
% of AUM
-40.7%
Top 10 Holdings %
Top 10 Hldgs %
5.8%
Holding
489
New
53
Increased
164
Reduced
226
Closed
46
Top Buys
| 1 |
D.R. Horton
DHI
|
$987K |
| 2 |
Lennar Class A
LEN
|
$952K |
| 3 |
Freeport-McMoran
FCX
|
$917K |
| 4 |
TJX Companies
TJX
|
$909K |
| 5 |
Ametek
AME
|
$905K |
Top Sells
| 1 |
Steel Dynamics
STLD
|
$1.65M |
| 2 |
NOA
North American Construction
NOA
|
$1.55M |
| 3 |
Alamos Gold
AGI
|
$1.53M |
| 4 |
Cheniere Energy
CQP
|
$1.51M |
| 5 |
GTY
Getty Realty Corp
GTY
|
$1.5M |
Sector Composition
| 1 | Healthcare | 26.88% |
| 2 | Financials | 12.6% |
| 3 | Technology | 10.15% |
| 4 | Materials | 9.55% |
| 5 | Real Estate | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Vaxcyte
PCVX
$4.32B
| $147K | 0.08% |
3,064
-2,846
| -48% | -$136K |
|
352
Viridian Therapeutics
VRDN
$1.5B
| $147K | 0.08% |
+5,017
| New | +$147K |
|
353
Prothena Corp
PRTA
$458M
| $146K | 0.08% |
2,416
-2,141
| -47% | -$129K |
|
|
MRTX
354
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $145K | 0.08% |
3,203
+1,214
| +61% | +$55K |
|
355
Syndax Pharmaceuticals
SNDX
$1.48B
| $145K | 0.08% |
5,701
-927
| -14% | -$23.6K |
|
356
Geron
GERN
$893M
| $144K | 0.08% |
59,604
-22,009
| -27% | -$53.3K |
|
357
Krystal Biotech
KRYS
$4.37B
| $143K | 0.07% |
1,804
-267
| -13% | -$21.2K |
|
358
Xenon Pharmaceuticals
XENE
$3.04B
| $143K | 0.07% |
3,616
-57
| -2% | -$2.25K |
|
|
CINC
359
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $142K | 0.07% |
+11,557
| New | +$142K |
|
|
RXDX
360
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $142K | 0.07% |
1,289
-2,895
| -69% | -$318K |
|
|
EQRX
361
DELISTED
EQRx, Inc. Common Stock
EQRX
| $141K | 0.07% |
57,405
+29,911
| +109% | +$73.6K |
|
362
Zentalis Pharmaceuticals
ZNTL
$125M
| $141K | 0.07% |
7,010
+2,191
| +45% | +$44.1K |
|
363
Pliant Therapeutics
PLRX
$110M
| $141K | 0.07% |
+7,303
| New | +$141K |
|
364
ALX Oncology
ALXO
$65.3M
| $141K | 0.07% |
12,484
-3,272
| -21% | -$36.9K |
|
|
IMGO
365
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $140K | 0.07% |
3,904
-4,285
| -52% | -$154K |
|
366
AbCellera Biologics
ABCL
$1.25B
| $140K | 0.07% |
13,827
+1,951
| +16% | +$19.8K |
|
367
Day One Biopharmaceuticals
DAWN
$771M
| $139K | 0.07% |
6,482
-119
| -2% | -$2.56K |
|
368
CION Investment
CION
$532M
| $139K | 0.07% |
14,304
+1,661
| +13% | +$16.2K |
|
369
Repare Therapeutics
RPTX
$73M
| $139K | 0.07% |
9,426
+1,789
| +23% | +$26.3K |
|
370
Alector
ALEC
$308M
| $138K | 0.07% |
14,933
+1,938
| +15% | +$17.9K |
|
371
Kodiak Sciences
KOD
$536M
| $138K | 0.07% |
19,214
+4,659
| +32% | +$33.4K |
|
372
Revolution Medicines
RVMD
$7.58B
| $137K | 0.07% |
5,771
-443
| -7% | -$10.6K |
|
373
Vir Biotechnology
VIR
$725M
| $137K | 0.07% |
5,408
+713
| +15% | +$18K |
|
374
Kezar Life Sciences
KZR
$30M
| $137K | 0.07% |
1,943
-271
| -12% | -$19.1K |
|
375
Lyell Immunopharma
LYEL
$231M
| $137K | 0.07% |
1,967
+811
| +70% | +$56.3K |
|